SWG Educational Activities
- 1) 25th-26th March 2021 Zurich/ virtual: Functional Precision Medicine in Blood Cancer (300+ participants)
- 2) 5th-7th September 2022 Helsinki: Functional Precision Medicine in Blood Cancer (onsite, 200+ participants)
- American Society of Hematology (ASH) webinar series on precision medicine Oct 11 2022: chaired by Caroline Heckman, Speakers: Anthony Letai, Philipp Staber
- Clinical trial promoted by and involving the SWG: EXALT-2 is a prospective, randomized, three arm study testing efficacy of treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice (Clinicaltrials.gov: NCT04470947)
Back